Skip to main content

Articles

1193 result(s) for 'cancer' within Journal of Ovarian Research

Page 2 of 24

  1. Bushen Tiaoxue Granules (BTG) is an empirical Chinese herbal formula that has been used for the treatment of subfertility. The protective effect of BTG on controlled ovarian hyperstimulation (COH)-induced impa...

    Authors: Jia-Cheng Zhang, Hao-Lin Zhang, Xi-Yan Xin, Yu-Tian Zhu, Xin Mao, Hang-Qi Hu, Yu-Xin Jin, Rui-Wen Fan, Xiao-Hui Zhang, Yang Ye and Dong Li
    Citation: Journal of Ovarian Research 2024 17:25
  2. Premature ovarian failure (POF) is a leading cause of women’s infertility without effective treatment. The purpose of this study was to investigate the protective effects of Luffa cylindrica fermentation liquid (...

    Authors: Yueying Feng, Wei Zhang, Xiaowei Xu, Wanzhen Wang, Yuanyuan Xu, Mengqi Wang, Jinfeng Zhang, Hengyi Xu and Fen Fu
    Citation: Journal of Ovarian Research 2024 17:24
  3. MUC16 is a heavily glycosylated cell surface mucin cleaved in the tumor microenvironment to shed CA125. CA125 is a serum biomarker expressed by > 95% of non-mucinous advanced stage epithelial ovarian cancers. MUC...

    Authors: Hsin-Fang Tu, Margaret Wong, Ssu-Hsueh Tseng, Nattha Ingavat, Pola Olczak, Kin Israel Notarte, Chien-fu Hung and Richard B.S. Roden
    Citation: Journal of Ovarian Research 2024 17:19
  4. This study was designed to investigate the pharmacological effects and mechanisms of ErZhiTianGui Decoction (EZTG) for age-related ovarian aging in mice.

    Authors: Jia Zhicheng, Li Yongqian, Wang Peixuan, Yang Kai, Shi Mengyu, Chen Wen, Liang Qihui and Guo Ying
    Citation: Journal of Ovarian Research 2024 17:12
  5. The etiology of polycystic ovary syndrome (PCOS) is complex and variable, and there is no exact cause or good treatment method. Most of the methods of hormones are used to temporarily meet the needs of patient...

    Authors: Shasha Gao, Juan Wang, Lun Wei, Chao Luo, Fei Qian, Le Bo and Caiping Mao
    Citation: Journal of Ovarian Research 2024 17:11
  6. Polycystic ovary syndrome (PCOS) is an exceedingly intractable issue affecting female endocrine and reproductive health. However, the etiology and intricate pathological mechanisms of PCOS remain unclear. Nowa...

    Authors: Danni Jiang, Yang Xu, Lin Yang, Pengfei Li, Xiaojuan Han, Qianni Li, Yang Yang and Lan Chao
    Citation: Journal of Ovarian Research 2024 17:7
  7. Investigating the utility of serum exosomal markers CA125, HE4, and C5a, both individually and in combination, for distinguishing between benign and malignant ovarian tumors.

    Authors: Huihui Shi, Liya Liu, Xueli Deng, Xiaoyu Xing, Yan Zhang, Yemeli Djouda Rebecca and Liping Han
    Citation: Journal of Ovarian Research 2024 17:4
  8. The objective of this study was to induce the differentiation of human theca stem cells (hTSCs) into germ cell-like cells (hGCLCs) and assess their developmental progression following in vitro 3D culture with ...

    Authors: Seyedeh Nasim Mirbahari, Christiani A. Amorim, Fatemeh Hassani, Mehdi Totonchi, Mahnaz Haddadi, Mojtaba Rezazadeh valojerdi and Azam Dalman
    Citation: Journal of Ovarian Research 2024 17:2
  9. Polycystic ovary syndrome (PCOS) is a widespread heterogeneous disease that is in association with genetic, epigenetic, endocrine and environmental factors. Adipose-derived mesenchymal stem cell (ASC) and ASC-...

    Authors: Golnaz Shafiei, Mona Saheli, Sepideh Ganjalikhan-hakemi, Tahereh Haghpanah and Seyed Noureddin Nematollahi-mahani
    Citation: Journal of Ovarian Research 2023 16:238
  10. As a novel prognostic and inflammatory marker, the systemic immune-inflammation index (SII) has come to the foreground in recent years. SII may be used as an indicator reflecting the progressive inflammatory p...

    Authors: Xin Li, Ting Luan, Yi Wei, Juan Zhang, JuanJuan Zhang, Chun Zhao and Xiufeng Ling
    Citation: Journal of Ovarian Research 2023 16:236
  11. The ovary is an important reproductive organ in mammals, and its development directly affects the sexual maturity and reproductive capacity of individuals. MicroRNAs (miRNAs) are recognized as regulators of re...

    Authors: Yanyan Wang, Jianmin Wang, Qing Li, Rong Xuan, Yanfei Guo, Peipei He and Tianle Chao
    Citation: Journal of Ovarian Research 2023 16:234
  12. Chromobox protein homolog 7 (CBX7), a member of the Polycomb repressor complex, is a potent epigenetic regulator and gene silencer. Our group has previously reported that CBX7 functions as a tumor suppressor in o...

    Authors: Yi Zhang, Roslyn Tedja, Michael Millman, Terrence Wong, Alexandra Fox, Hussein Chehade, Meyer Gershater, Nicholas Adzibolosu, Radhika Gogoi, Matthew Anderson, Thomas Rutherford, Zhenggang Zhang, Michael Chopp, Gil Mor and Ayesha B. Alvero
    Citation: Journal of Ovarian Research 2023 16:233
  13. The epithelial-mesenchymal transition (EMT) promotes cell signaling and morphology alterations, contributing to cancer progression. Exosomes, extracellular vesicles containing proteins...

    Authors: Germano Aguiar Ferreira, Carolina Hassibe Thomé, Clarice Izumi, Mariana Lopes Grassi, Guilherme Pauperio Lanfredi, Marcus Smolka, Vitor Marcel Faça and Francisco José Candido dos Reis
    Citation: Journal of Ovarian Research 2023 16:232
  14. Clinical trials are currently exploring combinations of PARP inhibitors and immunotherapies for the treatment of ovarian cancer, but their effects on the ovarian tumour...BRCA deficiencies can influence the respo...

    Authors: Salar Farokhi Boroujeni, Galaxia Rodriguez, Kristianne Galpin, Edward Yakubovich, Humaira Murshed, Dalia Ibrahim, Sara Asif and Barbara C. Vanderhyden
    Citation: Journal of Ovarian Research 2023 16:231
  15. Clinical prediction models play an important role in the field of medicine. These can help predict the probability of an individual suffering from disease, complications, and treatment outcomes by applying spe...

    Authors: Guan Guixue, Pu Yifu, Gao Yuan, Liu Xialei, Shi Fan, Sun Qian, Xu Jinjin, Zhang Linna, Zhang Xiaozuo, Feng Wen and Yang Wen
    Citation: Journal of Ovarian Research 2023 16:230
  16. The expression of leukocyte antigen-E (HLA-E), IFN-γ, CD3 and CD56 in clinical samples of ovarian cancer was detected by mutiplexed immunohistochemistry. The mechanism ... by IFN-γ was explored using human ovaria...

    Authors: Hui Zheng, Xiaolin Guan, Xin Meng, Ying Tong, Yanchun Wang, Suhong Xie, Lin Guo and Renquan Lu
    Citation: Journal of Ovarian Research 2023 16:229
  17. Ovarian cancer is a significant public health concern with a poor prognosis for epithelial ovarian cancer. To explore the potential of immunotherapy in treating epithelial ovarian cancer, we investigated the immu...

    Authors: Hua Yang, Xiangyu Gu, Rong Fan, Qun Zhu, Sen Zhong, Xirun Wan, Qian Chen, Lan Zhu and Fengzhi Feng
    Citation: Journal of Ovarian Research 2023 16:223
  18. The objective of this study is to investigate the effects of an ethanolic extract derived from Agaricus subrufescens on rat models exhibiting Polycystic Ovarian Syndrome (PCOS) induced by Letrozole.

    Authors: Sarad Pawar Naik Bukke, Bharghava Bhushan Rao Pathange, Srikanth Kumar Karumanchi, Jalaiah Marri, Revathi Boyina, Kavya Rachamsetty, Bhargavi Manchikalapati, Saidi Odoma and Bello Hussaini
    Citation: Journal of Ovarian Research 2023 16:221
  19. High-grade serous ovarian cancer (OvCa) is the most common type ... drug delivery system is needed to attack the cancer cells and induce apoptosis, overcome acquired drug...

    Authors: Melayshia McFadden, Santosh Kumar Singh, Briana Kinnel, Sooryanarayana Varambally and Rajesh Singh
    Citation: Journal of Ovarian Research 2023 16:220
  20. Angiogenesis and metastasis contributes substantially to the poor outcome of patients with ovarian cancer. We aimed to explore the role and ... in regulating angiogenesis and metastasis of human ovarian cancer. N...

    Authors: Yang Liu, Yan Li, Yanzhi Wu, Yiyue Zhao, Xi Hu and Chunyi Sun
    Citation: Journal of Ovarian Research 2023 16:219
  21. High-grade serous carcinoma (HGSC) is the most common and aggressive subtype of epithelial ovarian cancer, characterized by gain-of-function TP53...mutations originating in the fallopian tube epithelium. Therapeu...

    Authors: Madison Pereira, Alice Glogova, Jacob Haagsma, Julia Stewart, Trevor G. Shepherd and Jim Petrik
    Citation: Journal of Ovarian Research 2023 16:218
  22. Polycystic ovary syndrome (PCOS) is an endocrine disorder characterized by ovarian cysts, high androgen levels, and irregular menstruation. The causality between PCOS and breast cancer (BC) has been widely discus...

    Authors: Runxiang Cao, Lanlan Chen, Yutong Liu, Xuyutian Wang, Ruolin Ma, Qian Zhao and Ye Du
    Citation: Journal of Ovarian Research 2023 16:215
  23. No residual disease (CC 0) following cytoreductive surgery is pivotal for the prognosis of women with advanced stage epithelial ovarian cancer (EOC). Improving CC 0 resection rates...

    Authors: Diederick de Jong, Amudha Thangavelu, Timothy Broadhead, Inga Chen, Dermot Burke, Richard Hutson, Racheal Johnson, Angelika Kaufmann, Peter Lodge, David Nugent, Aaron Quyn, Georgios Theophilou and Alexandros Laios
    Citation: Journal of Ovarian Research 2023 16:214
  24. The therapeutic effect of poly (ADP-ribose) polymerase inhibitors (PARPi) monotherapy compared with platinum-based chemotherapy, and the impact to subsequent platinum-based chemotherapy after PARPi resistance wer...

    Authors: Yana Ma, Jiale Liu, Ning Li, Hualei Bu, Yongwen Huang, Chengjuan Jin, Hao Wen, Shuai Feng, Hui Zhang, Xiaorong Yang, Beihua Kong, Lingying Wu and Kun Song
    Citation: Journal of Ovarian Research 2023 16:209
  25. Premature ovarian insufficiency (POI) is an important cause of infertility characterized by the functional decline of the ovary. Granulosa cells (GCs) around oocytes are critical for folliculogenesis, and GC d...

    Authors: Dan Liu, Xiaohong Guan, Wenqiang Liu, Yanping Jia, Hong Zhou, Chenxiang Xi, Mei Zhao, Yuan Fang, Li Wu and Kunming Li
    Citation: Journal of Ovarian Research 2023 16:203
  26. Gynecologic cancers comprise malignancies in the female reproductive organs. Ovarian cancer ranks sixth in terms of incidence rates ... mortality rates. The stage at which ovarian cancer is diagnosed mainly deter...

    Authors: Khushbukhat Khan, Sameen Zafar, Yasmin Badshah, Naeem Mahmood Ashraf, Mehak Rafiq, Lubna Danish, Maria Shabbir, Janeen H. Trembley, Tayyaba Afsar, Ali Almajwal and Suhail Razak
    Citation: Journal of Ovarian Research 2023 16:202
  27. Herein, we explored the relationship between tumour microenvironment (TME) reprogramming and tissue invasion based on single-cell RNA sequencing (scRNA-seq) datasets. Interestingly, hypoxia, oxidative phosphoryla...

    Authors: Yuanfu Zhang, Shu Sun, Yue Qi, Yifan Dai, Yangyang Hao, Mengyu Xin, Rongji Xu, Hongyan Chen, Xiaoting Wu, Qian Liu, Congcong Kong, Guangmei Zhang, Peng Wang and Qiuyan Guo
    Citation: Journal of Ovarian Research 2023 16:200
  28. Premature ovarian failure (POF) is one of the leading causes of female infertility and is accompanied by abnormal endocrine, seriously affecting female quality of life. Previous studies have demonstrated that ...

    Authors: Wenjie Dai, Hong Yang, Bo Xu, Tiantian He, Ling Liu, Xiaoqian Ma, Jiaxue Ma, Guoqin Yang, Rui Si, Xiuying Pei, Xing Du and Xufeng Fu
    Citation: Journal of Ovarian Research 2023 16:198
  29. Ovarian cancer (OV) is the most fatal gynecological ... of cell death with an essential role in cancer progression, though studies focusing on prognostic patterns ... . Pathway analysis enriched several critical ...

    Authors: Jiani Yang, Chao Wang, Yue Zhang, Shanshan Cheng, Yanna Xu and Yu Wang
    Citation: Journal of Ovarian Research 2023 16:196
  30. Evaluating the efficacy of letrozole overlapped with gonadotropin-modified letrozole protocol (mLP) for diminished ovarian reserve (DOR) or advanced-age women with repeated cycles.

    Authors: Xiaojia Li, Jingbo Chen, Yang Zhao, Fengyi He, Meijun Zeng, Guijun Guan and Xiaomiao Zhao
    Citation: Journal of Ovarian Research 2023 16:193
  31. Cancer cells may develop resistance to cisplatin by ... , the exact mechanism of cisplatin in ovarian cancer remains unclear. Recent studies have shown that ... PAPSS1 as a cisplatin modulator in epithelial ovari...

    Authors: Lei Sun, Wei-Xue Ji, Yan Li, Ze-Lian Li, Can-Can Duan, Bai-rong Xia and Lan Xiao
    Citation: Journal of Ovarian Research 2023 16:187
  32. Tumor-associated lncRNAs regulated by epigenetic modification switches mediate immune escape and chemoresistance in ovarian cancer (OC). However, the underlying mechanisms...+, CD4+, and Treg tumor-infiltrating i...

    Authors: Lu Chen, Wujiang Gao, Li Lin, Chunli Sha, Taoqiong Li, Qi Chen, Hong Wei, Meiling Yang, Jie Xing, Mengxue Zhang, Shijie Zhao, Wenlin Xu, Yuefeng Li, Lulu Long and Xiaolan Zhu
    Citation: Journal of Ovarian Research 2023 16:186
  33. Opa interacting protein 5 (OIP5), which is a cancer/testis-specific gene, plays a cancer-promoting role in various types of human cancer. However, the role of OIP5 in the carcinogenesis and progression of ovarian...

    Authors: Xin Zhang, Wenjie Gu, Aiqin Lin, Renjie Duan, Likai Lian, Yuanyuan Huang, Tiechen Li and Qing Sun
    Citation: Journal of Ovarian Research 2023 16:185
  34. We aimed to determine whether adding metformin to carboplatin treatment would reduce the damage to ovarian reserve associated with carboplatin use.

    Authors: Sevgi Ayhan, Necati Hancerliogullari, Gurhan Guney, Murat Gozukucuk, Muzaffer Caydere, Sergul Selvi Guney, Aytekin Tokmak and Yusuf Ustun
    Citation: Journal of Ovarian Research 2023 16:184
  35. C-X-C motif chemokine ligand 9 (CXCL9), which is involved in the pathological processes of various human cancers, has become a hot topic in recent ... radiomic model to identify CXCL9 status in ovarian cancer (OC...

    Authors: Rui Gu, Siyi Tan, Yuping Xu, Donghui Pan, Ce Wang, Min Zhao, Jiajun Wang, Liwei Wu, Shaojie Zhao, Feng Wang and Min Yang
    Citation: Journal of Ovarian Research 2023 16:180
  36. Mature and immature teratomas are differentiated based on tumor markers and calcification or fat distribution. However, no study has objectively quantified the differences in calcification and fat distribution...

    Authors: Akari Nakamori, Hideaki Tsuyoshi, Tetsuya Tsujikawa, Makoto Orisaka, Tetsuji Kurokawa and Yoshio Yoshida
    Citation: Journal of Ovarian Research 2023 16:179
  37. Follicular development in mammalian ovaries is a complex and dynamic process, and the interactions and regulatory-feedback loop between the follicular microenvironment, granulosa cells (GCs), and oocytes can a...

    Authors: Ziwen Xu, Tongwei Zhang, Jingyi Hu, Junya Zhang, Guang Yang, Jiahuan He, Huihui Wang, Ran Jiang and Guidong Yao
    Citation: Journal of Ovarian Research 2023 16:175
  38. Some major challenges of ovarian tissue vitrification and transplantation include follicle apoptosis induced by cryopreservation and ischemia-reperfusion injury, as well as ovarian follicle loss during post-tr...

    Authors: Fei Wang, Yuan Tian, Liwen Huang, Tian Qin, Wenye Ma, Chengbin Pei, Bo Xu, Hang Han, Xinrui Liu, Pengge Pan, Xiaoli Yu, Qin Chang, Yanrong Wang, Shuya Zhang and Xiuying Pei
    Citation: Journal of Ovarian Research 2023 16:173

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.